HK1131789A1 - Improved antimicrobial peptides - Google Patents

Improved antimicrobial peptides

Info

Publication number
HK1131789A1
HK1131789A1 HK09109702.1A HK09109702A HK1131789A1 HK 1131789 A1 HK1131789 A1 HK 1131789A1 HK 09109702 A HK09109702 A HK 09109702A HK 1131789 A1 HK1131789 A1 HK 1131789A1
Authority
HK
Hong Kong
Prior art keywords
antimicrobial peptides
improved antimicrobial
improved
peptides
antimicrobial
Prior art date
Application number
HK09109702.1A
Other languages
English (en)
Inventor
Artur Schmidtchen
Martin Malmsten
Original Assignee
Pergamum Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pergamum Ab filed Critical Pergamum Ab
Publication of HK1131789A1 publication Critical patent/HK1131789A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1019—Tetrapeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
HK09109702.1A 2006-05-16 2009-10-21 Improved antimicrobial peptides HK1131789A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US80064406P 2006-05-16 2006-05-16
SE0601088 2006-05-16
PCT/SE2007/000477 WO2007133153A1 (en) 2006-05-16 2007-05-15 Improved antimicrobial peptides

Publications (1)

Publication Number Publication Date
HK1131789A1 true HK1131789A1 (en) 2010-02-05

Family

ID=38694156

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09109702.1A HK1131789A1 (en) 2006-05-16 2009-10-21 Improved antimicrobial peptides

Country Status (9)

Country Link
US (1) US8227406B2 (de)
EP (1) EP2021364B8 (de)
JP (1) JP5330230B2 (de)
KR (1) KR101487719B1 (de)
AU (1) AU2007250558B2 (de)
CA (1) CA2651990C (de)
HK (1) HK1131789A1 (de)
MX (1) MX2008014415A (de)
WO (1) WO2007133153A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8933029B2 (en) * 2001-08-24 2015-01-13 Carrus Capital Corporation Antimicrobial and anti-inflammatory peptides
EP2173389A2 (de) * 2007-06-25 2010-04-14 Lipopeptide AB Neue medizinische produkte
CZ301822B6 (cs) * 2008-03-04 2010-06-30 Ústav organické chemie a biochemie Akademie ved Ceské republiky, v.v.i. Peptid, zpusob jeho prípravy a jeho použití
EP2265631B1 (de) * 2008-03-04 2012-04-25 Ustav Organicke Chemie a Biochemie Akademie Ved Ceske Republiky, V.V.I. Neue antimikrobielle peptide und ihre anwendung
CZ301774B6 (cs) * 2008-06-10 2010-06-16 Ústav organické chemie a biochemie, Akademie ved CR v. v. i. Syntetické peptidy a jejich použití
GB0821721D0 (en) * 2008-11-27 2008-12-31 Hansa Medical Ab Antimicrobial therapy
JP2011178674A (ja) * 2010-02-26 2011-09-15 Tokai Univ 抗菌剤
EP2547700A1 (de) * 2010-03-17 2013-01-23 Universität Regensburg An das mia-protein (melanoma inhibitory activity) bindende peptide oder antikörper
WO2012033450A1 (en) * 2010-09-07 2012-03-15 Dermagen Ab Novel antimicrobial peptides
US9187541B2 (en) 2011-04-27 2015-11-17 The Regents Of The University Of California Anti-microbial peptides and methods of use thereof
US9987316B2 (en) * 2012-09-14 2018-06-05 Case Western Reserve University Probiotic controlling fungi and uses thereof
CN105142657A (zh) * 2013-03-29 2015-12-09 梅里麦克制药股份有限公司 软骨结合型融合蛋白
KR101599587B1 (ko) * 2013-10-11 2016-03-14 건국대학교 산학협력단 다제내성균에 대한 항균, 항진균, 항염증 활성을 보이는 프로태티아마이신 항생펩타이드 유도체 및 그 용도
US20190204312A1 (en) * 2016-09-16 2019-07-04 Technische Universität München Magnetic particle-binding peptides
CN110279844A (zh) * 2019-01-31 2019-09-27 浙江星杭泰乐生物医药有限公司 人工合成抗菌肽在制备抑菌消炎祛痘化妆品或外用药物制剂中的应用及抑菌消炎祛痘组合物

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
SE459005B (sv) 1985-07-12 1989-05-29 Aake Rikard Lindahl Saett att framstaella sfaeriska polymerpartiklar
US5912230A (en) 1991-11-01 1999-06-15 Periodontix, Inc. Anti-fungal and anti-bacterial histatin-based peptides
US5593866A (en) * 1992-08-21 1997-01-14 The University Of British Columbia Cationic peptides and method for production
US5733872A (en) 1993-03-12 1998-03-31 Xoma Corporation Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
AU1086595A (en) * 1993-11-08 1995-05-29 Demeter Biotechnologies, Ltd. Methylated lysine-rich lytic peptides and method of making same by reductive alkylation
JP3459314B2 (ja) * 1994-08-31 2003-10-20 社団法人農林水産技術情報協会 新規ペプチド、抗菌剤、新規ペプチド遺伝子、新規な組み換え体ｄｎａ及び新規ペプチドの製造法
GB9504761D0 (en) 1995-03-09 1995-04-26 Unilever Plc Amphiphilic peptide and analogs thereof
US5834430A (en) 1995-05-31 1998-11-10 Biosynth S.R.L. Potentiation of antibiotics
CA2192782C (en) * 1995-12-15 2008-10-14 Nobuyuki Takechi Production of microspheres
US6503881B2 (en) 1996-08-21 2003-01-07 Micrologix Biotech Inc. Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
CA2336030A1 (en) 1998-07-02 2000-01-13 Stichting Skeletal Tissue Engineering Group Amsterdam Bone cement with antimicrobial peptides
CN1433470A (zh) 1999-10-29 2003-07-30 启龙股份公司 奈瑟球菌的抗原性肽
US20030083244A1 (en) 2000-04-26 2003-05-01 Vernet Corine A.M. Novel proteins and nucleic acids encoding same
US8933029B2 (en) 2001-08-24 2015-01-13 Carrus Capital Corporation Antimicrobial and anti-inflammatory peptides
DE10160170A1 (de) 2001-12-07 2003-07-17 Ipf Pharmaceuticals Gmbh Neue antimikrobielle Bolisinpeptide
WO2004016653A2 (en) 2002-08-15 2004-02-26 Leukotech A/S Bactericidal, anti-apoptotic, pro-inflammatory and anti-inflammatory peptides of heparin-binding protein (hbp) or human neutrophil elastase
JP4154218B2 (ja) 2002-11-27 2008-09-24 寛紀 高麗 新規抗菌性ポリペプチドとその利用
WO2004058809A2 (en) 2002-12-26 2004-07-15 Affinium Pharmaceuticals, Inc. Novel essential bacterial polypeptides
SE0301431D0 (sv) 2003-05-19 2003-05-19 Dermagen Novel antimicrobial peptides
CA2525540A1 (en) 2003-05-30 2004-12-09 Intercell Ag Enterococcus antigens
ATE446549T1 (de) 2003-06-30 2009-11-15 Kyong-Ja Jung Verfahren und vorrichtung zum lagern und transferieren von behältern
AU2005288519A1 (en) * 2004-09-27 2006-04-06 Technion Research & Development Foundation Ltd. Fatty acid modified polylysines as antimicrobial agents
CA2629751A1 (en) 2004-11-12 2006-05-18 The University Of British Columbia Antimicrobial peptides
SE0402807D0 (sv) 2004-11-17 2004-11-17 Dermagen Ab Novel antimicrobial peptides

Also Published As

Publication number Publication date
CA2651990A1 (en) 2007-11-22
EP2021364A4 (de) 2009-11-25
WO2007133153A1 (en) 2007-11-22
KR20090027213A (ko) 2009-03-16
AU2007250558B2 (en) 2012-10-25
JP5330230B2 (ja) 2013-10-30
JP2009537515A (ja) 2009-10-29
WO2007133153A8 (en) 2009-07-23
EP2021364A1 (de) 2009-02-11
MX2008014415A (es) 2009-01-29
US20100159006A1 (en) 2010-06-24
US8227406B2 (en) 2012-07-24
AU2007250558A1 (en) 2007-11-22
EP2021364B1 (de) 2014-04-09
KR101487719B1 (ko) 2015-01-29
EP2021364B8 (de) 2014-05-21
CA2651990C (en) 2014-12-23

Similar Documents

Publication Publication Date Title
IL199835A0 (en) Novel antimicrobial peptides
EP2061886A4 (de) Kleine kationische antimikrobielle peptide
HK1131789A1 (en) Improved antimicrobial peptides
HRP20130109T1 (en) Caspofungin formulations
IL197413A0 (en) Compositions comprising selectively targeted antimicrobial peptides
EP2004674A4 (de) Antimikrobielles protein
IL240686A0 (en) Antimicrobial cyclic peptides
PL1849352T3 (pl) Kombajn
GB0601687D0 (en) Antimicrobial materials
ZA200810738B (en) Polypeptide
EP2017283A4 (de) Peptide
EP2010561A4 (de) Antimikrobielle peptide
HK1139421A1 (en) Antibacterial peptides
EP2046816A4 (de) Mit einem cystein-tag versehene variante von staphylokokken-protein-g
EP2123666A4 (de) Peptid
EP2017285A4 (de) Antimikrobielle lineare peptide
DK2021364T3 (da) Forbedrede antimikrobielle peptider
SG10201403126RA (en) Cyclic antimicrobial peptides
GB0618748D0 (en) Peptide
GB0605774D0 (en) Peptide
GB0703945D0 (en) Peptide
IL197675A0 (en) Peptides
EP2097439A4 (de) Neue peptide
EP2091959A4 (de) Verbesserte peptidzusammensetzung
GB0609920D0 (en) Peptides

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20180515